Cardiovascular Consequences of Repetitive Arousals over the Entire Sleep Duration

Table 4

Measurements of serum markers.

	Control	Test
NO/μmol·L^−1	46 (26)	46 (18)	N/S
ET-1/pg·ml^−1	1.58 (1.27, 2.68)	1.59 (1.04, 2.61)	N/S
IL-6/pg·ml^−1	0.63 (0.41, 0.88)	0.69 (0.46, 1.01)	N/S
CRP/pg·ml^−1	8.8 (4.8, 18.9)	6.6 (4.6, 18.1)	N/S
TNF-α/pg·ml^−1	0.86 (0.82, 0.96)	0.88 (0.84, 0.94)	N/S
VEGF/ng·ml^−1	0.15 (0.09, 0.23)	0.14 (0.09, 0.20)	N/S

NO, nitric oxide; ET-1, endothelin-1; IL-6, interleukin-6; CRP, C-reactive protein; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor; N/S, not significant.